Stefano Pessina spent half a century building a pharmacy ... This week, the Italian billionaire and biggest shareholder of Walgreens Boots Alliance, backed a deal to sell the company to a private ...

(Reuters) - Walgreens Boots Alliance's executive chair Stefano Pessina will almost double his stake in the US pharmacy group to about 30% as part of its takeover by private equity group Sycamore, the ...

Stefano Pessina will increase his stake in Walgreens from 17% to approximately 30% as part of Sycamore's $23.7 billion takeover. Walgreens' market value has dropped from over $100 billion post ...

Stefano Pessina, executive chairman of Walgreens Boots Alliance, is set to nearly double his stake in the pharmacy retail chain as part of the $10 billion take-private deal the company announced ...

Walgreens Boots Alliance will be taken private by Sycamore Partners for $10 billion, the buyout firm said on Thursday, ...

The executive chairman of Walgreens Boots Alliance (NASDAQ:WBA), Stefano Pessina, is expected to nearly double his company ...

The trouble started more than 10 years ago, when Italian billionaire Stefano Pessina ... fall of the 123-year-old Walgreens brand — or, as it's been known since Pessina tethered it to its ...

US pharmacy giant Walgreens Boots Alliance is going private. Will the new owners sell off the high-street chemist?

Walgreens Boots Alliance’s (WBA) executive chair Stefano Pessina will nearly double his stake in the U.S. pharmacy group to about 30% as part of its $10B takeover by private equity group ...

Many of the company’s missteps were under former CEO Stefano Pessina, also its largest single shareholder, whose 2007-2014 tenure at the helm saw Walgreens’ market capitalization shrink to ...

“It might be the only pharmacy in their community,” he said. Under the deal, Walgreens Executive Chairman Stefano Pessina, who owns 17% of Walgreens’ shares, will vote all his shares in ...

March 18 (Reuters) - Walgreens Boots Alliance's (WBA.O), opens new tab executive chair Stefano Pessina will almost double his stake in the U.S. pharmacy group to about 30% as part of its $10 ...